Tune Therapeutics

Tune Therapeutics

  • Founded: 2020
  • Location: Durham, NC
  • Employee range: 11 - 50
  • Funding: $40M Dec 2021



job board

Short description:

Epigenetic modification to modulate gene expression

Drug notes:

Contact us to add description: recruit@workinbiotech.com

Long description:

Tune Therapeutics is manipulating the epigenome using therapeutics to treat diseases. The epigenome determines how, when and where genes are expressed and drives characteristic differences between healthy and diseased cells. Tune has developed their proprietary TEMPO genetic tuning platform to exploit the master conductors of gene activity allowing the volume of gene expression to be precisely controlled. TEMPO has the advantages of multiplexing as well as regulating genes in their natural context and involves two switchable elements - a DNA binding domain and an effector subunit. Genetic tuning via the epigenome is a new class of treatments that Tune believes has the potential to be used to treat common and chronic diseases.


Tune Therapeutics
Senior Research Associate - Ex Vivo
Seattle, WA|11 days ago
Tune Therapeutics
Director of Regulatory
Seattle, WA or Durham, NC or Remote|26 days ago
Tune Therapeutics
Scientist Ex Vivo Developmental Biology
Seattle|38 days ago

© 2024 Work In Biotech LLC
Personal data

Terms of Service

Privacy Policy

Contact: recruit@workinbiotech.com